Clinical Trials Sponsored by Allife Medical Science and Technology Co., Ltd.

Total 211 results

Allife Medical Science and Technology Co., Ltd.

Not yet recruiting

Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

China
Allife Medical Science and Technology Co., Ltd.

Unknown

Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Refractory B-Cell Lymphoma
Allife Medical Science and Technology Co., Ltd.

Unknown

A Study of Autologous Induced Islet Body With Type 1 Diabetes

Type 1 Diabetes
Allife Medical Science and Technology Co., Ltd.

Unknown

A Clinical Study of iEPC Intervent Subjects With Cerebral Hemorrhagic Stroke

Stroke, Ischemic
Allife Medical Science and Technology Co., Ltd.

Unknown

Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Refractory B-Cell Lymphoma
Allife Medical Science and Technology Co., Ltd.

Unknown

Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer

Epithelial Ovarian Cancer
Allife Medical Science and Technology Co., Ltd.

Unknown

iHSCs With the Gene Correction of HBB Intervent Subjests With β-thalassemia Mutations

Thalassemia
Allife Medical Science and Technology Co., Ltd.

Unknown

A Clinical Study of iNSC Intervent Cerebral Hemorrhagic Stroke

Stroke, Ischemic
Allife Medical Science and Technology Co., Ltd.

Unknown

Study of BCMA CAR-T in Multiple Myeloma

Relapsed and Refractory Multiple Myeloma
Allife Medical Science and Technology Co., Ltd.
Tianjin People's Hospital

Recruiting

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

China
Allife Medical Science and Technology Co., Ltd.
Peking University Cancer Hospital & Institute

Unknown

Study of Anti-CD19 iCAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Refractory B-Cell Lymphoma
Allife Medical Science and Technology Co., Ltd.
Peking University Cancer Hospital & Institute

Unknown

Study of Anti-CD19/CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Refractory B-Cell Lymphoma
Allife Medical Science and Technology Co., Ltd.
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia

Critical Limb Ischemia

China
Wuhan Createrna Science and Technology Co., Ltd

Completed

A Study of Multiple Ascending Doses MY008211A in Healthy Adults

Paroxysmal Nocturnal Hemoglobinuria

China
Wuhan Createrna Science and Technology Co., Ltd

Completed

Effect of Food on Pharmacokinetics of MY008211A Tablets in Healthy Adult Subjects

Paroxysmal Nocturnal Hemoglobinuria

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

Leukemia

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Trial to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Multiple Myeloma

Multiple Myeloma

China
Beijing Immunochina Medical Science & Technology...

Not yet recruiting

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors

Melanoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors

Hepatocellular Carcinoma , Cholangiocarcinoma

China
Beijing Immunochina Medical Science & Technology...

Not yet recruiting

Donor-derived CAR-T Cells in the Treatment of AML Patients

AML

China
Beijing Immunochina Medical Science & Technology...

Unknown

Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation

Leukemia

China
Wuhan Createrna Science and Technology Co., Ltd

Recruiting

A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors

Liver Cancer

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

China
Beijing Immunochina Medical Science & Technology...

Completed

Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)

Leukemia

China
Beijing Immunochina Medical Science & Technology...

Unknown

Safety and Efficacy Evaluation of Decitabine With R-GDP

NHL

China
Beijing Immunochina Medical Science & Technology...

Unknown

Safety and Efficacy Evaluation of IM19 Cells

Hematological Malignancies

China
Wuhan Createrna Science and Technology Co., Ltd

Not yet recruiting

Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH)
Wuhan Createrna Science and Technology Co., Ltd

Completed

A Study of Single-dose MY008211A in Healthy Adults

Paroxysmal Nocturnal Hemoglobinuria

China
Beijing Immunochina Medical Science & Technology...

Not yet recruiting

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

Leukemia
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms

Digestive System Neoplasms | Advanced Solid Tumors | Pancreatic Cancer Resectable | Colorectal (Colon or Rectal) Cancer

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma

Gastric Cancer | Pancreatic Cancer | Advanced Solid Tumors | Esophagogastric Junction Cancer

China
Beijing Immunochina Medical Science & Technology...

Not yet recruiting

Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma

Neoplasms | Neoplasms by Histologic Type | Lymphoma | Lymphoproliferative Disorders | Lymphoma, Mantle-Cell
Beijing Immunochina Medical Science & Technology...

Completed

Safety and Efficacy Evaluation of IM23 CAR-T Cells (IM23CAR-T)

AML

China
Beijing Immunochina Medical Science & Technology...

Unknown

Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)

Leukemia

China
Shanghai Meiji Health Science and Technology Co...

Completed

Shanghai Meiji Health Science and Technology Co., Ltd

Over Weight People
Shanghai Meiji Health Science and Technology Co...

Completed

Clinical Trial for Liquid Food (Inslow)

Diabetes
Shanghai Meiji Health Science and Technology Co...

Completed

Clinical Trial for Vespa Amino Acid Mixture (VAAM®)

Sports Injury
Nanjing NingQi Medicine Science and Technology...

Unknown

Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

Non-small Cell Lung Cancer

China
Nanjing NingQi Medicine Science and Technology...

Unknown

Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma

Advanced Lung Squamous Carcinoma

China
CardioNavi MedTech (Wuhan) Co., Ltd.
Beijing Jingruitianhe Medical Science and Technology Development Co,Ltd

Recruiting

The StUdy to Evaluate the Performance and safEty of the Novasight HybRid System Using Objective PeRformance Criteria (SUPERIOR)

Coronary Artery Disease

China
Huazhong University of Science and Technology
REGEN-αGEEK (SHENZHEN) MEDICAL TECHNOLOGY CO., LTD.

Recruiting

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19

Long COVID-19 Syndrome

China
Beijing Immunochina Medical Science & Technology...
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients

NHL

China
Safe Save Medical Cell Sciences & Technology Co...

Unknown

ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme

Taiwan
Jiangsu Healthy Life Innovation Medical Technology...

Not yet recruiting

TTField in Combination With TMZ and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.

Glioblastoma Multiforme
Jiangsu Healthy Life Innovation Medical Technology...

Not yet recruiting

Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment

Non-small Cell Lung Cancer (NSCLC)

China
Jiangsu Healthy Life Innovation Medical Technology...

Not yet recruiting

Clinical Study of Tumor Treating Fields Combined With Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer

Locally Advanced Pancreatic Cancer

China
Guangzhou Saliai Stem Cell Science and Technology...

Unknown

Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn

Ocular Corneal Burn

China
Beijing Likang Life Science and Tech Co., Ltd.

Recruiting

Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors

Advanced Solid Tumor

China
Sichuan J.Z. Bio-chemical Science and Technology...

Unknown

Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients

GBM

China

Clinical Trials Sponsored by Allife Medical Science and Technology Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations